GSK teams up with US university in Aids research
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
YEARS ago, curing Aids was considered so out of the question that some scientists dared not even mention the possibility.
But in the latest sign that attitudes are changing, the British pharmaceutical giant GlaxoSmithKline is teaming up with the University of North Carolina at Chapel Hill to start a research institute and a company aimed at curing HIV infection and Aids.
Share with us your feedback on BT's products and services
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
